Mims' Medical Microbiology and Immunology

Höfundar: Richard Goering; Hazel M. Dockrell; Mark Zuckerman; Peter L. Chiodini (Útgáfa: 7)
Mims' Medical Microbiology and Immunology

Kaup valmöguleikar

MIMS’ Medical Microbiology and Immunology is loved internationally for its thorough yet easy-to-follow coverage of microbiology, infectious diseases, and immunology as a dynamic interplay between microbes and host. Covering the fundamentals of these closely linked disciplines, MIMS’ takes a systems approach to elaborate on epidemiology, clinical presentation, pathogenesis, and diagnostic approaches, as well as treatment and infection control considerations, supplemented by case-based examples.

Complex scientific and clinical concepts are explained clearly and simply with the help of illustrations and a range of accompanying online content. Students will come away with a deep understanding of topics and processes, and will return to this book for reference time and again. Clear writing and easy-to-understand explanations – perfect for students learning to grasp the fundamentals of both microbiology and immunologyUser-friendly format with colour coding, key concept boxes, and dynamic illustrations for easy navigationOrganised by body system – goes beyond the ‘bug parade’ to help you understand clinical contextPathogen Parade (electronic supplement) – a quick cross-referenced glossary of viruses, bacteria, parasites, and fungiVaccine Parade (electronic supplement) – quick-reference coverage of the most commonly used vaccines in current clinical practiceClinical cases and multiple-choice self-assessments (electronic supplement) support learning.

Nánar um bókina

Útgefandi
Elsevier Limited (UK)
ISBN
9780443107436
Print ISBN
9780323937252
Format
ePub
Útgáfa
7
Höfundar
Richard Goering; Hazel M. Dockrell; Mark Zuckerman; Peter L. Chiodini
Tungumál
English
Útgefið
2023-12-20
Prent takmörkun á líftíma
10

Kaflar

  • Cover image
  • Title page
  • Table of Contents
  • Copyright
  • Foreword to Mims Medical Microbiology, 7th Edition
  • Foreword to Mims Medical Microbiology, 6th Edition
  • Preface to the seventh edition
  • Contributors and acknowledgments
  • A contemporary approach to microbiology
  • Contents
  • List of Illustrations
  • List of Tables
  • Chapter 1: The Adversaries – Pathogens
  • Chapter 2: Pathogens as parasites
  • THE VARIETIES OF PATHOGENS
  • LIVING INSIDE OR OUTSIDE CELLS
  • SYSTEMS OF CLASSIFICATION
  • Chapter 3: The bacteria
  • Introduction
  • Structure
  • Nutrition
  • Growth and Division
  • Gene Expression
  • Survival Under Adverse Conditions
  • Mobile Genetic Elements
  • Mutation and Gene Transfer
  • The Genomics of Medically Important Bacteria
  • Chapter 4: The viruses
  • MAJOR GROUPS OF VIRUSES
  • INFECTION OF HOST CELLS
  • REPLICATION
  • OUTCOME OF VIRAL INFECTION
  • Some viruses can transform the host cell into a tumour or cancer cell
  • Tumour formation as a result of viral infection: direct and indirect mechanisms
  • Viral oncogenes have probably arisen from incorporation of host oncogenes into the viral genome during viral replication
  • Chapter 5: The fungi
  • MAJOR GROUPS OF DISEASE-CAUSING FUNGI
  • Chapter 6: The protozoa
  • Chapter 7: The helminths
  • LIFE CYCLES
  • HELMINTHS AND DISEASE
  • Chapter 8: The arthropods
  • Chapter 9: Prions
  • A SPECTRUM OF NEURODEGENERATIVE DISORDERS—TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY
  • ROGUE PROTEIN PATHOGENESIS
  • DEVELOPMENT, TRANSMISSION AND DIAGNOSIS OF PRION DISEASES
  • PREVENTION AND TREATMENT OF PRION DISEASES
  • Chapter 10: The host–parasite relationship
  • THE MICROBIOTA AND MICROBIOME
  • SYMBIOTIC ASSOCIATIONS
  • THE CHARACTERISTICS OF PARASITISM
  • THE EVOLUTION OF PARASITISM
  • Chapter 11: The adversaries – host defences
  • Chapter 12: The innate defences of the body
  • The body has both innate and adaptive immune defences
  • DEFENCES AGAINST ENTRY INTO THE BODY
  • DEFENCES ONCE THE MICROORGANISM PENETRATES THE BODY
  • Chapter 13: Adaptive immune responses bring specificity
  • LYMPHOID TISSUES: PRIMARY AND SECONDARY
  • SECONDARY LYMPHOID ORGANS
  • SUBSETS OF T CELLS
  • ANTIBODY STRUCTURE AND FUNCTION
  • RECIRCULATION OF T AND B CELLS
  • Chapter 14: Cooperation leads to effective immune responses
  • COOPERATION MEANS GREATER EFFICIENCY AND SPECIFICITY
  • OPSONIZATION BY ANTIBODY ENHANCES PHAGOCYTOSIS AND LEADS TO COMPLEMENT ACTIVATION
  • BENEFICIAL INFLAMMATORY REACTIONS CAN ALSO BE ENHANCED BY ANTIBODIES
  • ACTIVATION OF T CELLS INVOLVES ANTIGEN-PRESENTING CELLS AND ADDITIONAL COSTIMULATORY SIGNALS
  • B-CELL ACTIVATION
  • CLONAL EXPANSION
  • ANTIBODY PRODUCTION INVOLVES A SERIES OF STEPS WITHIN THE GERMINAL CENTRE
  • CYTOKINES PLAY AN IMPORTANT PART IN THESE CELL–CELL INTERACTIONS
  • IMMUNOLOGIC MEMORY ENABLES A SECOND INFECTION WITH THE SAME MICROBE TO BE DEALT WITH MORE EFFECTIVELY
  • ARMIES MUST BE KEPT UNDER CONTROL
  • Chapter 15: The Conflicts
  • Chapter 16: Background to the infectious diseases
  • HOST–PARASITE RELATIONSHIPS
  • CAUSES OF INFECTIOUS DISEASES
  • THE BIOLOGIC RESPONSE GRADIENT
  • Chapter 17: Entry, exit and transmission
  • SITES OF ENTRY
  • EXIT AND TRANSMISSION
  • TYPES OF TRANSMISSION BETWEEN HUMANS
  • TRANSMISSION FROM ANIMALS
  • Chapter 18: Immune defences in action
  • COMPLEMENT
  • ACUTE PHASE PROTEINS AND PATTERN RECOGNITION RECEPTORS
  • FEVER
  • NATURAL KILLER CELLS
  • PHAGOCYTOSIS
  • CYTOKINES
  • ANTIBODY-MEDIATED IMMUNITY
  • CELL-MEDIATED IMMUNITY
  • RECOVERY FROM INFECTION
  • Chapter 19: Spread and replication
  • FEATURES OF SURFACE AND SYSTEMIC INFECTIONS
  • MECHANISMS OF SPREAD THROUGH THE BODY
  • GENETIC DETERMINANTS OF SPREAD AND REPLICATION
  • OTHER FACTORS AFFECTING SPREAD AND REPLICATION
  • Chapter 20: Parasite survival strategies and persistent infections
  • PARASITE SURVIVAL STRATEGIES
  • CONCEALMENT OF ANTIGENS
  • ANTIGENIC VARIATION
  • IMMUNOSUPPRESSION
  • PERSISTENT INFECTIONS
  • Chapter 21: Pathologic consequences of infection
  • PATHOLOGY CAUSED DIRECTLY BY MICROORGANISMS
  • DIARRHOEA
  • PATHOLOGIC ACTIVATION OF NATURAL IMMUNE MECHANISMS
  • PATHOLOGIC CONSEQUENCES OF THE IMMUNE RESPONSE
  • SKIN RASHES
  • VIRUSES AND CANCER
  • Chapter 22: Clinical Manifestation and Diagnosis of Infections by Body System
  • Chapter 23: Upper respiratory tract infections
  • RHINITIS
  • PHARYNGITIS AND TONSILLITIS
  • PAROTITIS
  • OTITIS AND SINUSITIS
  • ACUTE EPIGLOTTITIS
  • ORAL CAVITY INFECTIONS
  • Chapter 24: Lower respiratory tract infections
  • Introduction
  • LARYNGITIS AND TRACHEITIS
  • DIPHTHERIA
  • WHOOPING COUGH
  • ACUTE BRONCHITIS
  • ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS
  • BRONCHIOLITIS
  • RESPIRATORY SYNCYTIAL VIRUS INFECTION
  • HANTAVIRUS PULMONARY SYNDROME
  • PNEUMONIA
  • BACTERIAL PNEUMONIA
  • VIRAL PNEUMONIA
  • PARAINFLUENZA VIRUS INFECTION
  • ADENOVIRUS INFECTION
  • HUMAN METAPNEUMOVIRUS INFECTION
  • HUMAN BOCAVIRUS INFECTION
  • INFLUENZA VIRUS INFECTION
  • MEASLES VIRUS INFECTION
  • CYTOMEGALOVIRUS INFECTION
  • TUBERCULOSIS
  • CYSTIC FIBROSIS
  • LUNG ABSCESS
  • FUNGAL INFECTIONS
  • PARASITIC INFECTIONS
  • Chapter 25: Urinary tract infections
  • ACQUISITION AND AETIOLOGY
  • PATHOGENESIS
  • CLINICAL FEATURES AND COMPLICATIONS
  • LABORATORY DIAGNOSIS
  • TREATMENT
  • PREVENTION
  • Chapter 26: Sexually transmitted infections
  • STIs AND SEXUAL BEHAVIOUR
  • SYPHILIS
  • OTHER CAUSES OF INGUINAL LYMPHADENOPATHY
  • OTHER CAUSES OF VAGINITIS AND URETHRITIS
  • HUMAN PAPILLOMAVIRUS INFECTION
  • Monkeypox, previously a rare viral zoonosis, emerged in 2022 as aN STI
  • HUMAN IMMUNODEFICIENCY VIRUS
  • Chapter 27: Gastrointestinal tract infections
  • DIARRHOEAL DISEASES CAUSED BY BACTERIAL OR VIRAL INFECTION
  • FOOD POISONING: BACTERIALTOXIN–ASSOCIATED DIARRHOEA
  • VIRAL CAUSES OF DIARRHOEA
  • HELICOBACTER PYLORI AND GASTRIC ULCER DISEASE
  • PARASITES AND THE GASTROINTESTINAL TRACT
  • MICROSPORIDIA
  • OTHER INTESTINAL PROTOZOA
  • SYSTEMIC INFECTION INITIATED IN THE GASTROINTESTINAL TRACT
  • Chapter 28: Obstetric and perinatal infections
  • INFECTIONS OCCURRING IN PREGNANCY
  • CONGENITAL INFECTIONS
  • INFECTIONS OCCURRING AROUND THE TIME OF BIRTH
  • Chapter 29: Central nervous system infections
  • INVASION OF THE CENTRAL NERVOUS SYSTEM
  • THE BODY’S RESPONSE TO INVASION
  • MENINGITIS
  • ENCEPHALITIS
  • NEUROLOGIC DISEASES OF POSSIBLE VIRAL AETIOLOGY
  • SPONGIFORM ENCEPHALOPATHIES CAUSED BY SCRAPIE-TYPE AGENTS
  • CNS DISEASE CAUSED BY PARASITES
  • BRAIN ABSCESSES
  • TETANUS AND BOTULISM
  • Chapter 30: Infections of the eye
  • CONJUNCTIVITIS
  • INFECTION OF THE DEEPER LAYERS OF THE EYE
  • Chapter 31: Infections of the skin, soft tissue, muscle and associated systems
  • Infections of the skin
  • BACTERIAL INFECTIONS OF SKIN, SOFT TISSUE AND MUSCLE
  • MYCOBACTERIAL DISEASES OF THE SKIN
  • FUNGAL INFECTIONS OF THE SKIN
  • PARASITIC INFECTIONS OF THE SKIN
  • MUCOCUTANEOUS MANIFESTATIONS OF VIRAL INFECTIONS
  • MEASLES VIRUS INFECTION
  • RUBELLA VIRUS INFECTION
  • OTHER MACULOPAPULAR RASHES ASSOCIATED WITH VIRAL INFECTIONS
  • OTHER INFECTIONS PRODUCING SKIN LESIONS
  • KAWASAKI DISEASE
  • VIRAL INFECTIONS OF MUSCLE
  • POSTVIRAL FATIGUE SYNDROME
  • PARASITIC INFECTIONS OF MUSCLE
  • JOINT AND BONE INFECTIONS
  • INFECTIONS OF THE HAEMOPOIETIC SYSTEM
  • Chapter 32: Vector-borne infections
  • Transmission of disease by vectors
  • ARBOVIRUS INFECTIONS
  • INFECTIONS CAUSED BY RICKETTSIAE
  • BORRELIA INFECTIONS
  • PROTOZOAL INFECTIONS
  • HELMINTH INFECTIONS
  • Chapter 33: Multisystem zoonoses
  • Viral haemorrhagic fever is a multisystem syndrome triggered by a group of viruses that cause severe damage to the vascular system
  • ARENAVIRUS INFECTIONS
  • EBOLA AND MARBURG HAEMORRHAGIC FEVERS
  • Q FEVER
  • ANTHRAX
  • PLAGUE
  • YERSINIA ENTEROCOLITICA INFECTION
  • TULARAEMIA
  • PASTEURELLA MULTOCIDA INFECTION
  • LEPTOSPIROSIS
  • RAT-BITE FEVER
  • BRUCELLOSIS
  • HELMINTH INFECTIONS
  • Chapter 34: Fever of unknown origin
  • DEFINITIONS OF FEVER OF UNKNOWN ORIGIN
  • CAUSES OF FUO
  • INVESTIGATION OF CLASSIC FUO
  • TREATMENT OF FUO
  • FUO IN SPECIFIC PATIENT GROUPS
  • INFECTIVE ENDOCARDITIS
  • Chapter 35: Infections in the compromised host
  • THE COMPROMISED HOST
  • INFECTIONS OF THE HOST WITH DEFICIENT INNATE IMMUNITY DUE TO PHYSICAL FACTORS
  • INFECTIONS ASSOCIATED WITH SECONDARY ADAPTIVE IMMUNODEFICIENCY
  • OTHER IMPORTANT OPPORTUNIST PATHOGENS
  • Chapter 36: Diagnosis and Control
  • Chapter 37: Diagnosis of infection and assessment of host defence mechanisms
  • AIMS OF THE CLINICAL MICROBIOLOGY LABORATORY
  • SPECIMEN PROCESSING
  • CULTIVATION (CULTURE) OF MICROORGANISMS
  • IDENTIFICATION OF MICROORGANISMS GROWN IN CULTURE
  • NONCULTURAL TECHNIQUES FOR THE LABORATORY DIAGNOSIS OF INFECTION
  • ANTIBODY DETECTION METHODS FOR THE DIAGNOSIS OF INFECTION
  • ASSESSMENT OF HOST DEFENCE SYSTEMS
  • PUTTING IT ALL TOGETHER: DETECTION, DIAGNOSIS AND EPIDEMIOLOGY
  • Chapter 38: Epidemiology and control of infectious diseases
  • WHAT IS EPIDEMIOLOGY?
  • OUTCOME MEASUREMENTS
  • TYPES OF EPIDEMIOLOGIC STUDIES
  • TRANSMISSION OF INFECTIOUS DISEASE
  • VACCINE EFFICACY
  • Chapter 39: Attacking the enemy: antimicrobial agents and chemotherapy
  • SELECTIVE TOXICITY
  • DISCOVERY AND DESIGN OF ANTIMICROBIAL AGENTS
  • CLASSIFICATION OF ANTIBACTERIAL AGENTS
  • RESISTANCE TO ANTIBACTERIAL AGENTS
  • CLASSES OF ANTIBACTERIAL AGENTS
  • INHIBITORS OF CELL WALL SYNTHESIS
  • INHIBITORS OF PROTEIN SYNTHESIS
  • INHIBITORS OF NUCLEIC ACID SYNTHESIS
  • ANTIMETABOLITES AFFECTING NUCLEIC ACID SYNTHESIS
  • OTHER AGENTS THAT AFFECT DNA
  • INHIBITORS OF CYTOPLASMIC MEMBRANE FUNCTION
  • URINARY TRACT ANTISEPTICS
  • ANTITUBERCULOSIS AGENTS
  • ANTIBACTERIAL AGENTS IN PRACTICE
  • ANTIBIOTIC ASSAYS
  • ANTIVIRAL THERAPY
  • ANTIFUNGAL AGENTS
  • ANTIPARASITIC AGENTS
  • CONTROL BY CHEMOTHERAPY VERSUS VACCINATION
  • CONTROL VERSUS ERADICATION
  • USE AND MISUSE OF ANTIMICROBIAL AGENTS
  • Chapter 40: Protecting the host: vaccination
  • VACCINATION: A 400-YEAR HISTORY
  • AIMS OF VACCINATION
  • VACCINES CAN BE OF DIFFERENT TYPES
  • NONSPECIFIC BENEFICIAL EFFECTS OF VACCINES
  • Chapter 41: Specific and nonspecific immunotherapy
  • ADOPTIVE IMMUNOTHERAPY WITH T CELLS
  • PASSIVE IMMUNOTHERAPY WITH ANTIBODIES
  • NONSPECIFIC CELLULAR MODULATION
  • CORRECTION OF HOST IMMUNODEFICIENCY
  • Chapter 42: Infection control
  • COMMON HOSPITAL INFECTIONS
  • IMPORTANT CAUSES OF HOSPITAL INFECTION
  • SOURCES AND ROUTES OF SPREAD OF HOSPITAL INFECTION
  • HOST FACTORS AND HOSPITAL INFECTION
  • CONSEQUENCES OF HOSPITAL INFECTION
  • PREVENTION OF HOSPITAL INFECTION
  • INVESTIGATING HAI
  • STERILIZATION AND DISINFECTION
  • Chapter 43: Pathogen parade
  • Viruses
  • Hepatitis Viruses
  • Bacteria
  • Spiral bacteria
  • Other Bacteria
  • Fungi
  • Helminths
  • Chapter 44: Vaccine parade
  • Chapter 45: Section 1: The Adversaries—Pathogens
  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Question 8
  • Question 9
  • Question 10
  • Question 11
  • Question 12
  • Question 13
  • Question 14
  • Question 15
  • Question 16
  • Chapter 46: Section 2: The Adversaries—Host Defences
  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Chapter 47: Section 3: The Conflicts
  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Question 8
  • Question 9
  • Question 10
  • Question 11
  • Question 12
  • Question 13
  • Question 14
  • Question 15
  • Question 16
  • Question 17
  • Question 18
  • Chapter 48: Section 4: Clinical Manifestation and Diagnosis of Infections by Body System
  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Question 8
  • Question 9
  • Question 10
  • Question 11
  • Question 12
  • Question 13
  • Question 14
  • Question 15
  • Question 16
  • Question 17
  • Question 18
  • Question 19
  • Question 20
  • Question 21
  • Question 22
  • Question 23
  • Question 24
  • Question 25
  • Question 26
  • Question 27
  • Question 28
  • Question 29
  • Question 30
  • Question 31
  • Question 32
  • Question 33
  • Question 34
  • Question 35
  • Question 36
  • Question 37
  • Question 38
  • Question 39
  • Question 40
  • Question 41
  • Question 42
  • Question 43
  • Question 44
  • Question 45
  • Question 46
  • Question 47
  • Question 48
  • Question 49
  • Question 50
  • Question 51
  • Question 52
  • Question 53
  • Question 54
  • Question 55
  • Question 56
  • Question 57
  • Question 58
  • Question 59
  • Question 60
  • Question 61
  • Chapter 49: Section 5: Diagnosis and Control
  • Question 1
  • Question 2
  • Question 3
  • Question 4
  • Question 5
  • Question 6
  • Question 7
  • Question 8
  • Question 9
  • Question 10
  • Question 11
  • Question 12
  • Question 13
  • Question 14
  • Question 15
  • Question 16
  • Question 17
  • Question 18
  • Question 19
  • Question 20
  • Question 21
  • Question 22
  • Question 23
  • Question 24
  • Chapter 50: Online Cases
  • Chapter 51: Bibliography – list of useful websites
  • Index